Skip to main content

Tracheal Intubation

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
Forces applied by laryngoscopeN/A1 trial
Active Trials
NCT01685320Completed30Est. Dec 2011
Eppendorf
EppendorfGermany - Hamburg
1 program
Intubation-induced Decrease in Heart Rate as an Indicator for Intraoperative BradycardiaN/A1 trial
Active Trials
NCT05160207Completed50Est. Jun 2022
Verona Pharma
Verona PharmaUK - London
1 program
confirmation of endotracheal tube positioningN/A1 trial
Active Trials
NCT05162313Unknown105Est. Jun 2023
Verathon
VerathonBC - Burnaby
1 program
CurarePHASE_41 trial
Active Trials
NCT02404142Completed64Est. Aug 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
VerathonCurare
Verona Pharmaconfirmation of endotracheal tube positioning
EppendorfIntubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia
BiocorpForces applied by laryngoscope

Clinical Trials (4)

Total enrollment: 249 patients across 4 trials

NCT02404142VerathonCurare

Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium

Start: Feb 2015Est. completion: Aug 201664 patients
Phase 4Completed
NCT05162313Verona Pharmaconfirmation of endotracheal tube positioning

Flow Sensor and Colourimetric Capnometer in Verifying Tracheal Tube Positioning in Term and Preterm Infants

Start: Feb 2022Est. completion: Jun 2023105 patients
N/AUnknown
NCT05160207EppendorfIntubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia

Intubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia

Start: Nov 2021Est. completion: Jun 202250 patients
N/ACompleted
NCT01685320BiocorpForces applied by laryngoscope

Force and Pressure Distribution Using Macintosh and GlideScope Laryngoscopes in Normal Airway: an in Vivo Study

Start: Jan 2011Est. completion: Dec 201130 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.